National Symposium on Hepatitis B & C

The 24th National Symposium on Hepatitis B & C will provide an update on the current management of chronic Hepatitis B and C.  The symposium will provide lectures, panel discussions and interactive cases, which would provide general gastroenterologists, ID physicians, GPs, nurses and community health workers with state of the art knowledge of how to treat HCV and HBV in primary and tertiary care settings.

24th NATIONAL SYMPOSIUM ON HEPATITIS B & C
Saturday 18th November

Building E
(Aikenhead Wing)
St Vincent’s Hospital Melbourne
27 Victoria Pde, Fitzroy
Melbourne
——————————————————————
INTERNATIONAL SPEAKER
Prof. Jean-Michel Pawlotsky Henri Mondor
University Hospital & University of Paris-Est
Paris, France

NATIONAL SPEAKERS
Prof. Gregory Dore
The Kirby Institute, UNSW
& St Vincent’s Hospital Sydney

Assoc. Prof. Benjamin Cowie
Melbourne Health &
Victorian Infectious Diseases Reference Laboratory
——————————————————————
PROGRAMME
8.00–8.30 am – Registration
8.30–8.35 am – Tea & Coffee
8.35–10.30 am – Welcome
——————————————————————
PLENARY SESSION 1
Treating HCV in the Prison – Ms. Lucy McDonald
Treating PWID (risk of reinfection) – Prof. Greg Dore
State of the Art Lecture on Treatment of HCV “HCV Resistance and DAA Failures” – Prof. Jean-Michel Pawlotsky

Panel Discussion
10.30–11.30 am

MORNING BREAKOUT SESSIONS
Including morning tea

  1. Treatment of HCV made easy—diagnosis, treatment work-up, antiviral therapy
  2. Diagnosis of cirrhosis in the community
  3. EC-partnership—eliminating HCV from Victoria
  4. HCV—when “treatment made easy” is no long easy

——————————————————————
11.30 –1.00 pm – PLENARY SESSION 2
HBV: Where are the gaps – increasing rates of diagnosis & treatment of HBV in Australia – Assoc. Prof. Ben Cowie

Expanding treatment access—who & why? – Dr. David Iser
Curing HBV: new targets and timelines. How? Why?  Prof. Jean-Michel Pawlotsky

Panel Discussion
1.00–1.45 pm
Lunch
1.45-3.00 pm

AFTERNOON BREAKOUT SESSIONS

  1. Hepatitis B 101: diagnosis, assessment of disease stage, treatment
  2. “Why don’t patients do what we ask them?” – HBV and “teach-back” method
  3. HCC & HCC—screening, diagnosis and treatment
  4. HBV – difficult cases

3.00–3.45 pm – PLENARY SESSION 3
New Horizons in Hepatitis C
The Australian Model – Prof. Greg Dore

Panel Discussion

FINISH
——————————————————————
MEETING ADMINISTRATOR
Ms. Beverly Cooper
Tel: (03) 9231 3581
Email: beverly.cooper@svha.org.au

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s